MORRIS I WISTAR III 4
4 · Immunome Inc. · Filed Oct 8, 2020
Insider Transaction Report
Form 4
Immunome Inc.IMNM
MORRIS I WISTAR III
10% Owner
Transactions
- Conversion
Common Stock
2020-10-06+38,464→ 38,464 total(indirect: See footnote) - Conversion
Warrant (right to buy)
2020-10-06−111,111→ 0 totalExercise: $9.00Exp: 2023-06-02→ Series A Convertible Preferred Stock (111,111 underlying) - Conversion
Warrant (right to buy)
2020-10-06+111,111→ 111,111 totalExercise: $9.00Exp: 2023-06-02→ Common Stock (111,111 underlying) - Conversion
Series A Convertible Preferred Stock
2020-10-06−38,464→ 0 total(indirect: See footnote)→ Common Stock (38,464 underlying) - Conversion
Series A Convertible Preferred Stock
2020-10-06−882,475→ 0 total→ Common Stock (882,475 underlying) - Conversion
Common Stock
2020-10-06+882,475→ 882,475 total
Footnotes (4)
- [F1]Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F2]The shares are held by Cotswold Foundation (the "Foundation"). the Reporting Person has voting and investment power with respect to shares held by the Foundation.
- [F3]Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F4]Immediately exercisable.